MedTrace Logo

Preventing Drug Abuse Among Sexual Minority Youth

NCT03954535 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1216

Last updated 2025-08-26

Study results available
· View outcomes & findings →

Summary

The planned randomized clinical trial will longitudinally test a tailored, web-based drug abuse prevention program with a nationwide sample of 15- to 17-year-old sexual minority youth (youth who identify as gay, lesbian, bisexual, or unsure of their sexual orientation).

Conditions

Interventions

BEHAVIORAL

Free2b

The intervention will consist of a website and 9 sessions. The intervention sessions will facilitate youths' acquisition of personal and social cognitive-behavioral skills. The intervention will focus on goal setting, decision making, enhancing self-worth, coping with stress, combating distorted thinking, communication skills, using alcohol and other drugs and a review session. Each session will require approximately 20 minutes and must be finished in a single sitting. Sessions will be delivered on a weekly basis. The website will include entertainment features and resources.

BEHAVIORAL

Attention-Placebo

Access to the website with entertainment features and resources - but no session content.

Sponsors & Collaborators

Principal Investigators

  • Traci M. Schwinn, PhD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-15
Primary Completion
2024-03-30
Completion
2024-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03954535 on ClinicalTrials.gov